Skip to content

LLY

Eli Lilly and Company

Capital expenditures, 2025
$7.8B
YoY, 2025
+55.0%
5-year CAGR
+41.4%
10-year CAGR
+22.1%

Capital expenditures

Capital expenditures by fiscal year

PeriodCapexYoY
2025$7.8B+55.0%
2024$5.1B+46.7%
2023$3.4B+85.9%
2022$1.9B+41.6%
2021$1.3B−5.6%
2020$1.4B+34.2%
2019$1.0B−14.6%
2018$1.2B+12.4%
2017$1.1B+3.8%
2016$1.0B−2.7%
2015$1.1B−8.3%
2014$1.2B+14.9%
2013$1.0B+11.8%
2012$905M+34.7%
2011$672M−3.2%
2010$694M−9.2%
2009$765M−19.2%
2008$947M−12.5%
2007$1.1B—